Brainstorm Cell Therapeutics reported 0 in Sales Revenues for its fiscal quarter ending in March of 2025.





Sales Change Date
Alterity Therapeutics Limited AUD 596.04K 584.66K Dec/2025
Biogen USD 2.25B 30M Mar/2026
Brainstorm Cell Therapeutics 0 0 Mar/2025
Cipla INR 65.41B 9.77B Mar/2026
Clal Biotechnology ILS 3.41M 2M Dec/2022
Compugen USD 6.35M 60.98M Mar/2026
CSL USD 8.33B 4.79B Dec/2025
Cytokinetics USD 19.35M 1.59M Mar/2026
Gilead Sciences USD 7B 930M Mar/2026
Grifols EUR 2B 306.7M Mar/2026
Halozyme Therapeutics USD 377M 74.76M Mar/2026
Mesoblast USD 30.3M 17.1M Dec/2025